Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis.
BACKGROUND
Diabetic retinopathy (DR) is a major sight-threatening diabetic complication. Previous studies have examined the association of DR with multiple genetic variants in the receptor for advanced glycation end products (RAGE) gene, with inconsistent results.


OBJECTIVE
To perform a systematic literature search and conduct meta-analyses to examine the association of genetic variants in RAGE with DR.


METHODS
PubMed, Cochrane Library, Embase, Google Scholar, and HuGE.


METHODS
Studies were on human subjects; the studies were case-control ones and included subjects who had DR and those who did not have DR; and the studies provided genotype data for genetic variants in RAGE, separately for subjects who had and did not have DR, or provided odds ratios (ORs) and the 95% confidence intervals (CIs), or provided sufficient data for the calculation of OR and the 95% CI.


METHODS
We used OR as a measure of association, and used random-effects model in all the meta-analyses. Between-study heterogeneity was assessed using I, and publication bias was evaluated using Egger test.


RESULTS
A total of 13 studies met the eligibility criteria and were included in our analyses. We found that Gly82Ser was significantly associated with DR (OR = 2.40, 95% CI: 1.46-3.97; P = 0.001) using a recessive model. -374T/A also showed significant association with DR under a dominant model (OR = 1.21, 95% CI: 1.03-1.43; P = 0.023). We did not find a significant association of DR with other genetic variants in RAGE.


CONCLUSIONS
The number of included studies is small for some genetic variants; duration of diabetes varied across studies; most studies were conducted in Asia; and it is not clear whether the observed association can be generalized to other ethnicities; and we could not control for other potential confounding factors.


CONCLUSIONS
We found that Gly82Ser in RAGE showed significant association with DR. More studies with larger sample sizes that control for important risk factors, such as duration of diabetes, are needed to validate our findings.
aDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China bRush Alzheimer's Disease Center, Rush University Medical Center cDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL dDepartment of Ophthalmology, People's Hospital of Beijing Daxing District, Beijing eDepartment of Ophthalmology, Traditional Chinese Medicine Hospital of Muping District of Yantai City, Shandong, China.
Weihong
W
Yu
Jingyun
J
Yang
Wenda
W
Sui
Bin
B
Qu
Ping
P
Huang
Youxin
Y
Chen
D016022:Case-Control Studies; D003930:Diabetic Retinopathy / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D000067759:Receptor for Advanced Glycation End Products / Q000235:genetics*; D012307:Risk Factors
C000593871:AGER protein, human; D000067759:Receptor for Advanced Glycation End Products
Diabetes Res Clin Pract. 2012 Mar;95(3):372-7
22154374
Res Synth Methods. 2010 Apr;1(2):97-111
26061376
Arch Ophthalmol. 2004 Apr;122(4):552-63
15078674
Genes Immun. 2002 May;3(3):123-35
12070776
BMC Med Genet. 2010 Nov 10;11:158
21067572
Indian J Ophthalmol. 2012 Sep-Oct;60(5):428-31
22944754
Diabetes Res Clin Pract. 2014 Apr;104(1):155-62
24529564
Diabetes Care. 1986 Jul-Aug;9(4):334-42
3743309
Clin Exp Ophthalmol. 2016 May;44(4):260-77
26716602
Ophthalmic Genet. 2010 Dec;31(4):244-51
21067489
Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):21-6
18709380
Curr Med Chem. 2009;16(8):940-52
19275604
J Diabetes Complications. 2002 Nov-Dec;16(6):391-4
12477623
Ophthalmologica. 2012;227(4):223-32
22354095
Arch Ophthalmol. 2006 Dec;124(12):1754-60
17159036
J Diabetes Res. 2013;2013:264579
24303504
Diabetes. 2009 Sep;58(9):2137-47
19587357
Diabetes. 1998 Jul;47(7):1155-7
9648842
Diabetes. 2001 Jun;50(6):1505-11
11375354
Gene. 2013 Jun 1;521(2):227-33
23545311
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3611-6
18441306
Diabet Med. 2005 Oct;22(10):1315-20
16176189
Mol Vis. 2007 Nov 26;13:2142-7
18079690
Diabetologia. 2015 May;58(5):1129-37
25687235
J Mol Neurosci. 2015 Jun;56(2):449-60
25682235
Retina. 2002 Feb;22(1):119-21
11884895
J Clin Endocrinol Metab. 2009 Dec;94(12):5174-80
19890027
PLoS One. 2008 Jun 25;3(6):e2546
18575614
Int J Environ Res Public Health. 2015 Jul 10;12(7):7899-909
26184262
Gene. 2012 May 25;500(1):1-9
22475522
Arch Biochem Biophys. 2003 Nov 1;419(1):80-8
14568011
Eye (Lond). 2007 Mar;21(3):395-401
16440015
PLoS One. 2015 Dec 14;10(12):e0144557
26658948
Diabetes Care. 2012 Mar;35(3):556-64
22301125
Fam Pract. 2004 Aug;21(4):447-53
15249536
Clin Exp Ophthalmol. 2012 Jan-Feb;40(1):27-38
21575125
J Endocrinol Invest. 2009 Mar;32(3):258-62
19542745
Klin Monbl Augenheilkd. 2003 Dec;220(12):873-6
14704946
PLoS Med. 2009 Jul 21;6(7):e1000097
19621072